Influence of HLA Class I and II Polymorphisms on COVID-19 Severity in a South Brazilian Population.

Publication date: Jun 02, 2025

Open Access PDF

Concepts Keywords
Antigen Adult
Brazilian Aged
Covid Alleles
Lost Brazil
Pcr coronavirus
COVID-19
Cross-Sectional Studies
Female
genetic
histocompatibility antigen classes
HLA-DR beta-chains
HLA-DRB1 Chains
HLA-DRB1 Chains
Humans
in silico model
Male
Middle Aged
polymorphism
Polymorphism, Genetic
SARS-CoV-2
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease IDO immune response
drug DRUGBANK Coenzyme M
disease MESH Parasitic Diseases
drug DRUGBANK Ribostamycin
disease IDO protein
disease MESH emergency
disease MESH asymptomatic infection
disease MESH critical illness
disease MESH death
disease MESH chronic conditions
pathway REACTOME Immune System
disease IDO host
disease MESH viral infections
disease MESH infection
disease IDO susceptibility
disease MESH diabetes mellitus
disease MESH Histocompatibility

Original Article

(Visited 1 times, 1 visits today)